Luminex Posts 2 Percent Rise in Q1 Revenues as Assay Sales Increase | GenomeWeb

NEW YORK (GenomeWeb) – Luminex reported after the close of the market Monday a 2 percent rise in its first quarter revenues, an increase helped by a 17 percent jump in assay revenues.

For the three-month period ended March 31, Luminex's revenues rose to $57.7 million from $56.6 million in the same period a year earlier, topping Wall Street analysts' average estimate of $56.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.